1
Clinical Trials associated with Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology) / Not yet recruitingPhase 1 A Phase I Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Autologous MitoCell (Adipose-Derived Mesenchymal Stem Cells) Transplantation in Subjects With Idiopathic Parkinson's Disease
Primary Objective: To assess the safety profile of autologous MitoCell administered to subjects with idiopathic Parkinson's disease (PD)
Secondary Objective: To explore the efficacy and safety of MitoCell given as the recommended dose by stereotactic intrastriatal implantation
100 Clinical Results associated with Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology)
100 Translational Medicine associated with Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology)
100 Patents (Medical) associated with Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology)
100 Deals associated with Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology)